Molecular modelling and the biosynthesis of apolipoprotein B containing lipoproteins

Atherosclerosis

Volumn 141, Issue SUPPL. 1, 1998, Pages

  Scott, James ^a   Navaratnam, Naveenan ^b   Carter, Charles ^c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Molecular modelling; Mutagenesis; Sequence alignment

Indexed keywords

APOLIPOPROTEIN B; CYTIDINE DEAMINASE; LIPOPROTEIN;

AMINO ACID SEQUENCE; CONFERENCE PAPER; CRYSTAL STRUCTURE; DEAMINATION; DIMERIZATION; ENZYME SPECIFICITY; ESCHERICHIA COLI; LIPOPROTEIN SYNTHESIS; MOLECULAR MODEL; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN TERTIARY STRUCTURE; RNA BINDING;

ESCHERICHIA COLI;

EID: 0031744353     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00213-5     Document Type: Conference Paper

References (37)

1. Kane JP. Apolipoprotein B: structural and metabolic heterogeneity. Annu Rev Physiol 1983;45:637-50.
2. Knott TJ, Pease RJ, Powell LM, Wallis SC, Rail SCJ, Innerarity TL, et al. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 1986;323:734-8.
3. Yang CY, Chen SH, Gianturco SH, Bradley WA, Sparrow JT, Tanimura M, et al. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Nature 1986;323:738-42.
4. Powell LM, Wallis SC, Pease RJ, Edwards YH, Knott TJ, Scott J. A novel form of tissue-specific RNA processing produces apolipoprotein B-48 in intestine. Cell 1987;50:831-40.
5. Chen S-H, Habib G, Yang CY, Gu ZW, Lee BR, Weng SA, et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon. Science 1987;238:363-6.
6. Scott J. A place in the world for RNA editing. Cell 1995;81:833-6.
7. Smith HC, Sowden MP. Base-modification mRNA editing through deamination-the good, the bad and the unregulated. Trends Genet 1996;12:418-24.
8. Navaratnam N, Morrison JR, Bhattacharya S, Patel D, Funahashi T, Giannoni F, et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J Biol Chem 1993;268:20709-12.
9. Teng B, Burant CF, Davidson NO. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 1993;260:1816-9.
10. Betts L, Xiang S, Short SA, Wolfenden R, Carter CWJ. Cytidine deaminase. The 2.3 Å crystal structure of an enzyme: transition-state analog complex. J Mol Biol 1994;235:635-56.
11. Bhattacharya S, Navaratnam N, Morrison JR, Scott J, Taylor WR. Cytosine nucleoside/nucleotide deaminases and apolipoprotein B mRNA editing. Trends Biochem Sci 1994;19:105-6.
12. Nakamuta M, Oka K, Krushkal J, Kobayashi K, Yamamoto M, Li WH, et al. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (APOBEC-1) gene in mice. Structure and evolution of APOBEC-1 and related nucleoside/nucleotide deaminases. J Biol Chem 1995;270:13042-56.
13. Xiang S, Short SA, Wolfenden R, Carter CW Jr. Transition state selectivity for a single hydroxyl group during catalysis by cytidine deaminase. Biochemistry 1995;34:4516-23.
14. Xiang S, Short SA, Wolfenden R, Carter CW Jr. Cytidine deaminase complexed to 3-deazacytidine. A 'valence-buffer' in zinc enzyme catalysis. Biochemistry 1996;35(5):1335-41.
15. Driscoll DM, Zhang Q. Expression and characterization of p27, the catalytic subunit of the apolipoprotein B mRNA editing enzyme. J Biol Chem 1994;269:19843-7.
16. Yamanaka S, Poksay KS, Balestra ME, et al. Cloning and mutagenesis of the rabbit ApoB mRNA editing protein. A zinc motif is essential for catalytic activity, and noncatalytic activity auxiliary factor(s) of the editing complex are widely distributed. J Biol Chem 1994;269:21725-34.
17. Anant S, MacGinnitie AJ, Davidson NO. APOBEC-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J Biol Chem 1995;270:14762-7.
18. MacGinnitie AJ, Anant S, Davidson NO. Mutagenesis of APOBEC-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity. J Biol Chem 1995;270:14768-75.
19. Navaratnam N, Bhattacharya S, Fujino T, Patel D, Jarmuz AL, Scott J. Evolutionary origins of apo B mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 1995;81:187-95.
20. Lau PP, Chen S-H, Wang JC, Chan L. A 40 kilodalton rat liver nuclear protein binds specifically to apolipoprotein B mRNA around the RNA editing site. Nucleic Acids Res 1990;18:5817-21.
21. Bostrom K, Lauer SJ, Poksay KS, Garcia Z, Taylor JM, Innerarity TL. Apolipoprotein B-48 RNA editing in chimeric apolipoprotein EB mRNA. J Biol Chem 1989;264:15701-8.
22. Davies MS, Wallis SC, Driscoll DM, Wynne JK, Williams GW, Powell LM, Scott J. Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cells. J Biol Chem 1989;264:13395-8.
23. Driscoll DM, Wynne JK, Wallis SC, Scott J. An in vitro system for the editing of apolipoprotein B mRNA. Cell 1989;58:519-25.
24. Chen S-H, Li XX, Liao WS, Wu JH, Chan L. RNA editing of apolipoprotein B mRNA. Sequence specificity determined by in vitro coupled transcription editing. J Biol Chem 1990;265:6811-6.
25. Hodges P, Scott J. Apolipoprotein B mRNA editing: a new tier for the control of gene expression. Trends Biochem Sci 1992;17:77-81.
26. Backus JW, Smith HC. Apolipoprotein B mRNA sequences 3′ of the editing site are necessary and sufficient for editing and editosome assembly. Nucleic Acids Res 1991;19:6781-6.
27. Backus JW, Smith HC. Three distinct RNA sequence elements are required for efficient apolipoprotein B (apo B) RNA editing in vitro. Nucleic Acids Res 1992;20:6007-14.
28. Shah RR, Knott TJ, Legros JE, Navaratnam N, Greeve JC, Scott J. Sequence requirements for the editing of apolipoprotein B mRNA. J Biol Chem 1991;266:16301-4.
29. Smith HC. Apolipoprotein B mRNA editing: the sequence to the event. Semin Cell Biol 1993;4:267-78.
30. Backus JW, Schock D, Smith HC. Only cytidines 5′ of the apolipoprotein B mRNA mooring sequence are edited. Biochim Biophys Acta 1994;1219:1-14.
31. Navaratnam N, Fujino T, Bayliss J, Jarmuz A, How A, Richardson N, et al. Escherichia coli cytidine deaminase provides a molecular model for apo B RNA editing and a mechanism for RNA substrate recognition. J Mol Biol 1998;275:695-714.
32. Higgins DG, Sharp PM. CLUSTAL: a package for performing multiple sequence alignment on a microcomputer. Gene 1988;73(1):237-44.
33. Stein P, Chothia C. Serpin tertiary structure transformation. J Mol Biol 1992;221:615-21.
34. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987;329:506-12.
35. Kuyper, L., Carter, C.W.J., 1996. Resolving crystal polymorphisms by finding 'stationary points' from quantitative analysis of crystal growth response surfaces. J Crystal Growth.
36. Sowden M, Hamm JK, Smith HC. Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing. J Biol Chem 1996;271:3011-7.
37. Yamanaka S, Poksay KS, Driscoll DM. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif. J Biol Chem 1996;271:11506-10.